Meloxicam Completed Phase 2 Trials for Hysterectomy Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01084161Study to Evaluate the Efficacy, Safety and Tolerability of N1539